<DOC>
	<DOCNO>NCT00944736</DOCNO>
	<brief_summary>The purpose study determine effect probiotic formulation , VSL # 3 , intestinal permeability pediatric patient Crohn 's disease .</brief_summary>
	<brief_title>Effect VSL # 3 Intestinal Permeability Pediatric Crohn 's Disease</brief_title>
	<detailed_description>Children Crohn 's disease alter intestinal permeability . A pilot study child show probiotic may decrease intestinal permeability . In double blind , randomize control trial , observe effect VSL # 3 small bowel permeability use double sugar absorption test . PCDAI monitor , analyze .</detailed_description>
	<mesh_term>Crohn Disease</mesh_term>
	<criteria>Current diagnosis small bowel colonic Crohn 's disease define histological endoscopic criterion . Males female age 1117 year . Crohn 's disease remission define Pediatric Crohn 's Disease Activity Index ( PCDAI ) &lt; 10 Patients maintenance dos aminosalicylates , 6MP and/or Azathioprine least 2 month . Procurement write informed consent sign subject 's legal guardian study investigator ( ) patient assent . Patients document intestinal stricture . Patients sign symptom systemic intestinal infection . Antibiotic use previous 1 month . Probiotic use previous 2 month ( exclude yogurt ) . Use following medication ; Methotrexate , Cyclosporine , Tacrolimus Infliximab . Patients diagnosis comorbid diseases heart disease , renal disease , immunodeficiency , diabetes , thyroid disease . Patients indwell catheter . Patients short bowel syndrome Positive urine pregnancy test female subject</criteria>
	<gender>All</gender>
	<minimum_age>11 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>Crohn 's Disease</keyword>
	<keyword>Pediatric</keyword>
	<keyword>VSL # 3</keyword>
	<keyword>Permeability</keyword>
	<keyword>Probiotic</keyword>
	<keyword>Zonulin</keyword>
</DOC>